Patient-Directed Neurofeedback for AD/HD

Authors

  • Thomas R. Rossiter

DOI:

https://doi.org/10.1300/J184v02n04_05

Abstract

The study reports on Patient-Directed neurofeedback for Attention Deficit/Hyperactivity Disorder (AD/HD). Therapist involvement was limited to 10 treatment sessions used to train the patient or parents of younger children to use the equipment, to monitor treatment, and to make changes in the treatment protocol as necessary. The remaining 50 sessions were conducted at home using inexpensive, easy to operate, 1 or 2 channel Lexicor PODS. Results from the initial 6 patients, ages 7 to 45, are reported. Thirteen of 24 Test of Variables of Attention (TOVA) measures (attention, impulsivity, reaction time and variability) were below average (SS c 90) at baseline. After 30 neurofeedback sessions, only 5 TOVA variables remained below average. It is concluded that Patient-Directed neurofeedback may be an effective alternative to Therapist-Directed treatment for many AD/HD patients and can be delivered at substantially less cost.

Downloads

Published

2016-12-18

Issue

Vol. 2 No. 4 (1998)

Section

SCIENTIFIC FEATURES

License

© International Society for Neurofeedback and Research (ISNR), all rights reserved. This article (the “Article”) may be accessed online from ISNR at no charge. The Article may be viewed online, stored in electronic or physical form, or archived for research, teaching, and private study purposes. The Article may be archived in public libraries or university libraries at the direction of said public library or university library. Any other reproduction of the Article for redistribution, sale, resale, loan, sublicensing, systematic supply, or other distribution, including both physical and electronic reproduction for such purposes, is expressly forbidden. Preparing or reproducing derivative works of this article is expressly forbidden. ISNR makes no representation or warranty as to the accuracy or completeness of any content in the Article.  From 1995 to 2013 the Journal of Neurotherapy was the official publication of ISNR (www. Isnr.org); on April 27, 2016 ISNR acquired the journal from Taylor & Francis Group, LLC. In 2014, ISNR established its official open-access journal NeuroRegulation (ISSN: 2373-0587; www.neuroregulation.org).